Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 41-50 of 52

Page
per page
  1. MPEP Hydrochloride
    A3633 MPEP Hydrochloride
    Target: Glutamate (Metabotropic) Group I Receptors
    Summary: MGlu5 receptor antagonist
      Soluble in DMSO
  2. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  3. AUY922 (NVP-AUY922)
    A4057 AUY922 (NVP-AUY922)
     1 Citation
    Target: HSP90
    Summary: Potent Hsp90 inhibitor
      ≥23.27 mg/mL
  4. ML130 (Nodinitib-1)
    B1646 ML130 (Nodinitib-1)
    Target: NOD1
    Summary: Potent and selective inhibitor of NOD1
      Soluble in DMSO
  5. FRAX597
    B1162 FRAX597
     1 Citation
    Target: PAK
    Summary: PAK inhibitor,potent and ATP-competitive
      ≥27.9 mg/mL
  6. NU7441 (KU-57788)
    A8315 NU7441 (KU-57788)
     4 Citation
    Target: PI3K|DNA-PK
    Summary: DNA-PK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.13 mg/mL
  7. KW 2449
    A4123 KW 2449
    Target: Aurora Kinases|FLT3|Bcr-Abl
    Summary: Multikinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.6 mg/mL
  8. AMD-070
    A3173 AMD-070
    Target: CXCR
    Summary: CXCR4 antagonist,potent and selective
      ≥17.45 mg/mL
  9. NU 7026
    A8649 NU 7026
    Target: PI3K|DNA-PK|ATM
    Summary: DNPK inhibitor,ATP-competitive and potent
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  10. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL

Items 41-50 of 52

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 5item
  4. CXCR 1 item
  5. Raf 2item
  6. Aurora Kinases 3item
  7. mTOR 2item
  8. MMP 3item
  9. Androgen Receptors 1 item
  10. FLT3 2item
  11. LPA Receptors 1 item
  12. P-glycoprotein (P-gp) 1 item
  13. PLK 1 item
  14. ULK1 1 item
  15. Eph Receptors 1 item
  16. VEGFR 4item
  17. PDGFR 4item
  18. c-Kit 2item
  19. RET 1 item
  20. Phosphodiesterases (PDEs) 1 item
  21. Bcr-Abl 2item
  22. FGFR 2item
  23. Voltage-gated Sodium (NaV) Channels 2item
  24. Src 1 item
  25. ROCK 2item
  26. PAK 1 item
  27. p300 1 item
  28. DNA-PK 3item
  29. HSP90 1 item
  30. eIF4E/eIF3G interaction 1 item
  31. RAD51 1 item
  32. LRRK2 1 item
  33. Voltage-gated Calcium Channels (CaV) 1 item
  34. Melanocortin (MC) Receptors 1 item
  35. HIV-1 gp120 1 item
  36. Glutamate (Metabotropic) Group I Receptors 1 item
  37. Synthases/Synthetases 1 item
  38. NPY Receptors 1 item
  39. Na /K ATPases 1 item
  40. P110 1 item
  41. Hck 1 item
  42. Catechol O-Methyltransferase (COMT) 1 item
  43. angiogenesis 1 item
  44. Histone Acetyltransferases (HATs) 1 item
  45. NOD1 1 item
  46. DCLK2 1 item
  47. gp120/CD4 1 item
  48. ATM 1 item
Reported Experiments
  1. Animal Experiments 41item
  2. Cell Experiments 34item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 5item
  5. Cancer 30item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 3item
  12. Glioblastoma 3item
  13. Glioma 3item
  14. HIV 2item
  15. Leukemia 3item
  16. Lung Cancer 4item
  17. Lymphoma 1 item
  18. Melanoma 1 item
  19. Multiple Myeloma 3item
  20. Myelofibrosis 1 item
  21. Neuroblastoma 3item
  22. Neurocognitive Disorders 1 item
  23. Non-small Cell Lung Carcinoma 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Osteoporosis 1 item
  26. Ovarian Cancer 2item
  27. Pancreatic Cancer 3item
  28. Prostate Cancer 4item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 1 item
  31. Schizophrenia 1 item
  32. Soft Tissue Sarcoma 1 item
  33. Thyroid Cancer 1 item